Chang‐Mei Liu
- Developmental Neuroscience top 2%
- Neurogenesis and neuroplasticity mechanisms 19
- Cancer Research top 5%
- MicroRNA in disease regulation 14
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 10
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 13
- RNA Interference and Gene Delivery 10
- Histone Deacetylase Inhibitors Research 7
- Biological Psychiatry top 10%
-
- Nerve injury and regeneration 10
-
- Genetics and Neurodevelopmental Disorders 10
Chang‐Mei Liu
100 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 121
- Developmental Neuroscience 303
- Cancer Research 509
- Neurology 186
- Molecular Biology 1.4k
- Biological Psychiatry 42
Countries citing papers authored by Chang‐Mei Liu
This map shows the geographic impact of Chang‐Mei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Mei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Mei Liu more than expected).
Fields of papers citing papers by Chang‐Mei Liu
This network shows the impact of papers produced by Chang‐Mei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Mei Liu. The network helps show where Chang‐Mei Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chang‐Mei Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 15 | |
| 12 | 2022 | 96 | |
| 13 | 2022 | 13 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 135 | |
| 16 | 2019 | 3 | |
| 17 | 2019 | 11 | |
| 18 | 2015 | 8 | |
| 19 | 2005 | 44 | |
| 20 | 2004 | 4 |
About Chang‐Mei Liu
Chang‐Mei Liu is a scholar working on Developmental Neuroscience, Neurology and Cancer Research, having authored 107 papers that have together received 2.1k indexed citations. Recurring topics across this work include Neurogenesis and neuroplasticity mechanisms (19 papers), MicroRNA in disease regulation (14 papers), Epigenetics and DNA Methylation (13 papers), RNA Interference and Gene Delivery (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (10 papers), Nerve injury and regeneration (10 papers), Genetics and Neurodevelopmental Disorders (10 papers) and Histone Deacetylase Inhibitors Research (7 papers). The work is most often cited by research in Developmental Neuroscience (303 citations), Cancer Research (509 citations) and Neurology (186 citations). Chang‐Mei Liu has collaborated with scholars based in China, United States and India. Frequent co-authors include Zhao‐Qian Teng, Xinyu Zhao, Keith E. Szulwach, Weixiang Guo, Peng Jin, De‐Pei Liu, Chih‐Chuan Liang, Peipei Liu, Nicholas J. Santistevan and Shang‐Kun Dai. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.